Trans-Canada Capital’s ASML ASML Stock Holding History

Trans-Canada Capital’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.6M	Buy	+14,396	New	+$22.9M	1.57%	5

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trans-Canada Capital's ASML Position: Q2 2026 in Review

Trans-Canada Capital opened a new position in ASML (ASML) in Q2 2026: 14,396 shares worth $28.6M. The stake represents 1.57% of the portfolio and ranks #5 among its holdings.

2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Trans-Canada Capital held 14,396 shares of ASML worth $28.6M as of Q2 2026.
ASML was a new Trans-Canada Capital position in Q2 2026.
ASML made up 1.57% of Trans-Canada Capital's portfolio in Q2 2026, its #5 holding.
2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Trans-Canada Capital's 13F filing for Q2 2026, filed 13 Aug 2026.